Exosomes – tiny biological nanoparticles which transfer information between cells – offer significant potential in detecting and treating disease, the most comprehensive overview so far of research in the field has concluded.
Areas which could benefit include cancer treatment and regenerative medicine, say Dr Steven Conlan from Swansea University, Dr Mauro Ferrari of Houston Methodist Research Institute in Texas, and Dr Inês Mendes Pinto from the International Iberian Nanotechnology Laboratory in Portugal. Their commissioned paper, Exosomes as Reconfigurable Therapeutic Systems, is published today by Cell Press in Trends in Molecular Medicine.
Exosomes are particles produced by all cells in the body and are from 30-130 nanometres in size – a nanometre is one-billionth of a metre. They act as biological signalling systems, communicating between cells, carrying proteins, lipids, DNA and RNA. They drive biological processes, from modulating gene expression to transmitting information through breast milk.
Though discovered in 1983, the full potential of exosomes is only gradually being revealed. The researchers show that the nanoparticles’ possible medical benefits fall into three broad categories:
- Detecting disease – by acting as disease-specific biomarkers
- Activating immune responses to boost immunity
- Treating diseases – serving as the vehicle for drugs, for example bearing cancer therapies as their payload, to target tumours
One of the most useful properties of exosomes is that they are able to cross barriers such as the plasma membrane of cells, or the blood/brain barrier. This makes them well-suited to delivering therapeutic molecules in a very targeted way.
The potential benefits of exosomes can be seen in the wide range of research projects – cited in the paper – already either completed or under way, in areas such as:
- Improved testing for prostate cancer
- A small-cell lung cancer trial
- Stem cell-derived exosomes strengthening heart muscles
- Regeneration of muscle and tissue
The team caution that there is more to do before research into exosomes translates into new techniques and treatments. Side-effects need to be considered, and a standardised approach to isolating, characterising and storing exosomes will need to be developed.
Researchers will also need to ensure that the properties of exosomes do not end up causing harm: for example they can transfer drug resistance and pacify the immune system.
Nevertheless, the potential is very clear, with the team describing exosomes as “increasingly promising”.
Professor Steve Conlan of Swansea University Medical School, one of the authors of the paper, said:
“Our survey of research into exosomes shows clearly that they offer enormous potential as a basis for detecting and treating disease.
Further studies are necessary to turn this research into clinical outcomes, but researchers and funders should be very encouraged by our findings. Our own research in Swansea is investigating the use of exosomes and exosome-like synthetic nanoparticles in combatting ovarian and endometrial cancer.
Progress in this field depends on partnership. As the authorship of our own paper illustrates, researchers in different countries are increasingly working together in nanohealth. Swansea University has wider links with Houston and Portuguese based researchers in the field.
It’s also important to build partnerships outside academia, in particular with government and companies in this fast-growing sector.”
The Latest on: Exosomes
Nobel laureate, respected researchers talk exosomes in APS President's Symposium series
on April 17, 2018 at 1:05 pm
San Diego (April 17, 2018) -- APS President Dennis Brown, PhD, of Harvard Medical School and Massachusetts General Hospital, has organized a thought-provoking President's Symposium Series for the American Physiological Society (APS) annual meeting at ... […]
Exosome Diagnostics Obviates Tissue Biopsies
on April 17, 2018 at 3:25 am
Exosome Diagnostics presents evidence that breast cancer exosomes isolated from plasma of stage 1 and stage 2 breast cancer patients gives the same RNA signature as matched tumor tissue. Waltham, MA, April 17, 2018 (GLOBE NEWSWIRE) -- This groundbreaking ... […]
ZenBio, Inc Awarded a Phase I SBIR Grant to Develop Extracellular Vesicles and Exosomes to Treat Age-related Tendinopathy
on April 16, 2018 at 11:53 pm
RESEARCH TRIANGLE PARK, NC – 04-17-2018 (Press Release Jet) — ZenBio, Inc. announced that it has been awarded a Phase I SBIR grant to develop novel stem cell-based therapeutics to treat tendinopathy that occurs with aging. The award from the National ... […]
Global Exosomes Market Challenges & Industry Analysis by 2018-2025
on April 12, 2018 at 1:11 pm
Brooklyn, NY -- (SBWIRE) -- 04/12/2018 -- Qyresearchreports include new market research report "Global Exosomes Market Size,Status and Forecast 2025" to its huge collection of research reports. This report, Exosomes Market is a result of extensive research ... […]
ArunA biomedical study published in Stroke, exosomes improved recovery in stroked pigs
on April 12, 2018 at 9:41 am
ArunA Biomedical today announced the publication of data demonstrating that neural stem cell-derived extracellular vesicles (NSC EVs) improved tissue and functional recovery in pigs following ischemic stroke. Published in today's issue of Stroke, this is ... […]
How are Exosomes Isolated?
on April 12, 2018 at 2:02 am
Exosomes are extracellular vesicles that are believed to play a role in communication between cells by transporting materials inside the vesicle. Credit: Alex_Traksel/Shutterstock.com Exosomes are released from cells upon fusion with an intermediate ... […]
What are Exosomes?
on April 9, 2018 at 5:30 am
Exosomes are vesicles, or cellular components, that exist outside of a cell. They are generally understood as having been released from cells upon fusion with an intermediate endocytic compartment, or a multivesicular body (MVB). When the MVB fuses with ... […]
New tools for exosome analysis: Applying imaging flow cytometry to cancer-derived exosomes
on March 27, 2018 at 5:00 pm
Exosomes, a type of small extracellular vesicle (EV) ranging in size from 30–200 nm in diameter, can be isolated from cell culture media as well as an array of biological fluids. There is considerable interest in analyzing the phenotypic characteristics ... […]
Innovative genetic therapy strategy for pancreatic cancer
on July 17, 2017 at 5:51 pm
Genetic manipulation of exosomes, virus-sized particles released by all cells, may offer a new therapeutic approach to treating pancreatic cancer, according to a study at The University of Texas MD Anderson Cancer Center. Findings from the study ... […]
via Google News and Bing News